Ldl-stimulated microglial activation exacerbates ischemic white matter damage

Luo-Qi Zhou1, Yun-Hui Chu1, Ming-Hao Dong1

  • 1Department of Neurology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China.

PubMed

Insights

Vessel-adjacent microglia activated by leaked LDL in chronic cerebral hypoperfusion impair the blood-brain barrier and cause white matter damage. Lowering LDL levels protected against this demyelination.

Area of Science:

  • Neuroscience
  • Immunology
  • Cerebrovascular Biology

Background:

  • The role of microglia in blood-brain barrier (BBB) impairment and white matter damage following chronic cerebral hypoperfusion remains poorly understood.
  • Microglia are the primary immune cells of the central nervous system, responding to injury and disease.

Purpose of the Study:

  • To investigate the specific mechanisms by which microglia contribute to BBB breakdown and white matter damage in chronic cerebral hypoperfusion.
  • To identify the molecular triggers and cellular responses of microglia in this pathological context.

Main Methods:

  • Utilized models of chronic cerebral hypoperfusion.
  • Investigated the interaction between plasma low-density lipoprotein (LDL) leakage and microglia activation.
  • Analyzed microglial phagocytosis, lipid burden, and inflammatory/regenerative profiles.
  • Employed microglia-specific knockdown of LDL receptor (LDLR) and systemic LDL-lowering medication.

Main Results:

  • Vessel-adjacent microglia were specifically activated by leaked plasma LDL, leading to BBB breakdown and ischemic demyelination.
  • LDL stimulation enhanced microglial phagocytosis of myelin debris, resulting in lipid-laden microglia with suppressed inflammatory and pro-regenerative properties.
  • Microglia-specific LDLR knockdown and systemic LDL reduction conferred protection against ischemic demyelination.

Conclusions:

  • LDL-stimulated, vessel-adjacent microglia exhibit a unique molecular signature with suppressed regenerative capacity, exacerbating demyelination in ischemic white matter damage.
  • Targeting LDL levels or LDLR in microglia presents a potential therapeutic strategy for mitigating white matter injury in chronic cerebral hypoperfusion.